Skip to content

FARR MILLER & WASHINGTON LLC/DC: AVGO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of FARR MILLER & WASHINGTON LLC/DC on AVGO, newest first. How the timeline and the estimate are built.

FARR MILLER & WASHINGTON LLC/DC held 1,032 AVGO shares at 2021-09-30 per its 13F-HR filed 2021-11-15.

the latest 13F is the newest step

  1. period ended2021-09-30
    13F 1,032 shares
    Change vs previous 13F 0 shares

    0.03% of the 13F portfolio, value $500,000.

    13F-HR 0001034184-21-000008 filed by FARR MILLER & WASHINGTON LLC/DC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2021-06-30
    13F 1,032 shares
    Change vs previous 13F 0 shares

    0.03% of the 13F portfolio, value $492,000.

    13F-HR 0001034184-21-000005 filed by FARR MILLER & WASHINGTON LLC/DC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-03-31
    13F 1,032 shares
    Change vs previous 13F -243 shares

    0.03% of the 13F portfolio, value $478,000.

    13F-HR 0001034184-21-000004 filed by FARR MILLER & WASHINGTON LLC/DC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2020-12-31
    13F 1,275 shares
    Change vs previous 13F +25 shares

    0.04% of the 13F portfolio, value $558,000.

    13F-HR 0001034184-21-000001 filed by FARR MILLER & WASHINGTON LLC/DC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2020-09-30
    13F 1,250 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $455,000.

    13F-HR 0001034184-20-000007 filed by FARR MILLER & WASHINGTON LLC/DC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).